Tarsus Pharmaceuticals, Inc. Tech Stack

Biopharmaceutical company scaling eye-care drug commercialization and clinical operations

Pharmaceutical Manufacturing Irvine, California 201–500 employees Founded 2017 Public Company

Tarsus is a publicly traded biotech company with a research-and-sales-led hiring mix (research 9 roles, sales 7) oriented around launching and scaling its lead eye-care therapeutic. Active projects span pre-clinical formulation work, QMS system implementation, and managed-care strategy — indicating simultaneous investment in manufacturing maturity, regulatory infrastructure, and market access. Pain points cluster around managed care complexity, vendor relationships, and process automation, typical friction points for biotech firms transitioning from R&D into commercial-stage operations.

Tech Stack 21 technologies

Core StackSAP Oracle Power BI Tableau NetSuite Salesforce Canva ServiceNow SAS Veeva IQVIA Microsoft Project Project Server Planview Veeva Vault Minitab JMP Adaptive Planning FloQast

What Tarsus Pharmaceuticals, Inc. Is Building

◆Challenges

Managed care hurdles
Launching new product
Complex selling environment
Maximizing managed care opportunities
Managing vendor relationships for reporting
Increasing efficiency through automation
Managing external research collaborations
Supplier quality management
Investigation and deviation management
Inefficiencies in contract processes

▲Active Projects

Launch and ongoing growth of xdemvy
Ongoing performance monitoring
Pre-clinical animal model formulation
Integrated development plan
Operationalizing new in-house laboratory facilities
External research collaborations with cros
Blinded studies support
Qms system implementation
Medical communication strategy development
Poster and presentation generation

Hiring Activity

Accelerating35 roles · 25 in 30d

Department

Research

Sales

Healthcare

Quality

Compliance

Engineering

Executive

Seniority

Senior

Manager

Director

Mid

Lead

Notable leadership hires: Program Team Lead

Company intelligence

Find more companies like Tarsus Pharmaceuticals, Inc. by tech stack, pain points and active projects

Get started free

About Tarsus Pharmaceuticals, Inc.

Tarsus is a biopharmaceutical company founded in 2017 and publicly listed on Nasdaq, headquartered in Irvine, California. The company focuses on eye-care therapeutics, with active commercialization efforts around its lead product. Operationally, Tarsus combines clinical development (pre-clinical animal model work, blinded studies, external CRO partnerships) with commercial infrastructure (managed care navigation, medical communications, sales execution). Current hiring spans research, clinical, sales, and quality functions across the United States and Peru, with accelerating velocity across 33 open roles.

HeadquartersIrvine, California

Company Size201–500 employees

Founded2017

Hiring MarketsUnited States, Peru

Frequently Asked Questions

What is Tarsus Pharmaceuticals working on?

Active programs include launch and growth of its lead eye-care product (Xdemvy), pre-clinical formulation work, operationalizing in-house laboratory facilities, QMS system rollout, managed-care strategy development, and external research collaborations with CROs.

What tech stack does Tarsus use?

Core platforms include Veeva (clinical/quality), SAP and Oracle (ERP), Salesforce (CRM), ServiceNow (IT operations), Power BI and Tableau (analytics), IQVIA (pharma data), and Planview (project management).

How this profile is built

Tarsus Pharmaceuticals, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.